[ad_1]
Quik Research
Kuik Research’s Recent Report Analyzes Top 330 Pharma Biotech Companies in China with Clinical Trials Insights
DELHI, September 04, 2023 (GLOBE NEWSWIRE) — China Pharmaceutical Company Database and Drugs Pipeline Insight 2023 Main characteristics:
- All companies are domestic Chinese companies
- Chinese Pharmaceuticals Companies Business Overview Insights: 330 Companies
- Comprehensive information on drugs in clinical trials by companies: > 1500 drugs
- Clinical trial insights, indications, formulations and phases by companies
- Comprehensive information on commercially approved drugs on the market: > 200 drugs
- Classification of Biosimilar, Branded and Generic Medicines
Download Sample: /ccformF.php?t=1693561853
China has successfully established itself as a major player in the global life sciences industry, and local pharmaceutical companies and research institutions have played an important role in this. Beijin, Shanghai Pharmaceuticals and Seastone Pharmaceuticals are some of the life science focused companies that have achieved immense success over the years due to their strong research base and expertise in commercialization of products. The Chinese government has also played a big role in this. For example, there are many life science parks, such as Zhongguancun Life Science Park and Tianfu Life Science Park, which are hotspots for academic-business synergy. These have helped researchers to lead their research to clinical development and application.
China’s life sciences industry is one of the largest in the world, and is still growing at an incredibly fast pace. It is giving stiff competition to the established markets of the US and EU, and is emerging as the fastest growing life sciences industry in Asia-Pacific. To spread their bases to other countries and increase their value in the global market, Chinese life science companies are also setting up centers in different countries, which gives them access to large patient bases for clinical trials and the most up-to-date research. provide. development facilities. The Chinese life science industry is growing rapidly, which is expected to continue in the years to come.
Contact: Neeraj Chawla KUICK Research Head of Research [email protected] 
Source
[ad_2]
